Weight loss injections on the NHS or private: what to know

Weight loss injections—particularly tirzepatide (Mounjaro) and semaglutide (Wegovy)—have generated significant interest, partly because media coverage has focused on celebrity use and partly because people have had genuine success losing weight. If you’re considering these medicines, understanding how they work, what the NHS actually provides, and the real dangers of buying from unregulated sellers is essential.

How tirzepatide and semaglutide work

Both tirzepatide (Mounjaro) and semaglutide (Wegovy) are injectable medications that reduce appetite and help you feel fuller for longer. They work by activating receptors for gut hormones that normally regulate hunger. The medications also slow digestion, which keeps your blood sugar more stable after meals—an effect that helps both with weight management and blood sugar control in diabetes.

The difference is that semaglutide targets one hormone receptor (GLP-1), while tirzepatide targets two (GLP-1 and GIP), which some evidence suggests may make tirzepatide slightly more effective for weight loss in some people. Both are given as weekly injections under the skin, usually in the abdomen, thigh, or arm.

Importantly, these medicines work best alongside diet and exercise changes. They are not a substitute for lifestyle changes; they are a tool to help you make those changes by suppressing appetite. If you stop taking the injection, appetite returns and weight regain commonly occurs.

NHS eligibility: tirzepatide and semaglutide

The NHS does prescribe both medications, but eligibility is restricted and tiered. For tirzepatide, you will usually be prescribed it for weight loss only if your BMI meets specific thresholds, which vary depending on whether you’re being treated by your GP or a specialist weight management service. Your doctor will assess your individual circumstances and may be more likely to prescribe if you have weight-related health conditions such as type 2 diabetes, high blood pressure, or joint problems.

For semaglutide, NHS eligibility similarly requires a specific BMI threshold and referral to a specialist weight management service in most cases. The NHS is more likely to offer semaglutide if you have obesity combined with cardiovascular conditions—previous heart attack, stroke, or peripheral arterial disease—in addition to being overweight.

Neither medication is available on the NHS simply because someone wants to lose weight. The NHS approach is to reserve these medicines for people whose weight poses a significant health risk and for whom diet and exercise alone have not worked sufficiently. Waiting times for NHS weight management services are often long, and not everyone who applies will be approved.

Private prescribing: what it requires

If you pursue private weight loss injection treatment, several things must be true for it to be legitimate. First, you must be assessed by a registered medical prescriber—a doctor, registered nurse, or another healthcare professional with prescribing authority in the UK. Legitimate private providers ask about your medical history, contraindications, and motivations, and they do not prescribe to everyone who asks.

Second, the medicine must be supplied by a registered pharmacy in the UK or obtained through a legitimate pharmaceutical route. It must be an MHRA-licensed version of the medicine (branded as Mounjaro or Wegovy) or a pharmacologically equivalent version that is licensed in the UK. Third, your prescriber must arrange follow-up care—weight loss injection treatment is not a one-off; it requires monitoring for side effects and assessment of effectiveness.

Private weight loss injection treatments typically cost hundreds of pounds per month. Some private providers offer packages with nutritional support, exercise coaching, or behavioural counselling alongside the injections, which adds to the cost.

Side effects and safety considerations

Common side effects of both tirzepatide and semaglutide include nausea, vomiting, diarrhoea or constipation, and reduced appetite (which is partly the mechanism). These effects often fade as your body adjusts. Some people experience dizziness, fatigue, or changes in taste.

More serious but rare side effects include pancreatitis (inflammation of the pancreas, causing severe abdominal pain) and gallbladder problems such as gallstones, which NHS medicines guidance lists for both drugs. Semaglutide’s NHS guidance also lists diabetic retinopathy (worsening eye problems) as a possible serious side effect if you have type 2 diabetes. The patient information leaflet for each medicine sets out its own specific warnings and contraindications, so read it, or ask your prescriber, before starting treatment. If you develop severe abdominal pain, vision changes, or vomiting, stop the injection and seek medical care immediately.

Pregnancy is a contraindication; these medicines should not be used during pregnancy or if you’re trying to conceive. NHS guidance says to stop tirzepatide at least four weeks, and semaglutide at least two months, before you start trying to conceive.

The danger of counterfeit and unregulated online suppliers

This is where the real risk lies. The MHRA (Medicines and Healthcare Products Regulatory Agency) has issued multiple warnings about fake weight loss injections circulating online. Counterfeit Mounjaro pens and vials have been identified being sold through illegal online pharmacies. These fake medicines may contain no active ingredient, incorrect dosages, harmful substances, or contaminants.

Buying weight loss injections from websites without verifying they are registered UK pharmacies puts you at serious risk. Fake medicines can cause no effect, allergic reactions, infections (if sterility was compromised during manufacturing), or harm from whatever substance they actually contain. The MHRA has also noted that illegal online weight-loss medicine sellers often operate from organized crime networks.

To verify a pharmacy is registered, you can check the GPhC (General Pharmaceutical Council) register of UK pharmacies on their website. If an online pharmacy is not on this register, it is not legally operating in the UK. Legitimate private prescribers will supply medicines from registered pharmacies, not from mysterious websites offering discounts or no-questions-asked treatment.

What happens if you stop taking the injection

Weight regain is common if you stop taking tirzepatide or semaglutide without maintaining the diet and exercise changes you made whilst on it. Some people regain all the weight they lost; others maintain part of it. There is no gradual taper; you simply stop the weekly injection. The appetite-suppressing effect wears off within days to weeks, and your normal appetite returns.

Some people take these medicines long-term, viewing them as chronic weight management treatment similar to how someone might take a blood pressure medication long-term. Others use them for a defined period to lose weight, then stop and rely on lifestyle changes to maintain the loss. Discuss your plan with your doctor or prescriber.

Key points

• Tirzepatide (Mounjaro) and semaglutide (Wegovy) reduce appetite by activating gut hormone receptors; they work best with diet and exercise changes
• NHS eligibility requires specific BMI thresholds and is typically more restrictive than private availability; waiting times are often long
• Private prescribing requires assessment by a registered medical prescriber and supply from a registered UK pharmacy
• Common side effects include nausea and diarrhoea; rare but serious side effects include pancreatitis, gallbladder problems, and, for semaglutide, diabetic retinopathy
• Counterfeit weight loss injections are circulating through illegal online sellers; the MHRA warns against buying from unregistered sources
• Verify a pharmacy’s registration on the GPhC register before purchasing
• Weight regain often occurs if you stop taking the injection without maintaining lifestyle changes

Related: Health